University of California San Francisco

Dr. Garrett Roll large headshot
Garrett
Roll
MD

Associate Professor of Surgery
Division of Transplant Surgery

Address

35 Medical Center Way, #001
San Francisco, CA 94143
United States

    Biography

    Dr. Roll completed both general surgery training and the abdominal organ transplant fellowship at the University of California San Francisco. During his training, Dr. Roll spent 2 years in Dr. Holger Willenbring's laboratory investigating liver cell therapy, as well as normal and pathologic liver regeneration. After fellowship Dr. Roll moved to England to become a Senior International Fellow in Liver Transplant and Multi Organ Procurement at Queen Elizabeth Hospital, Birmingham, one of the busiest liver transplant departments in the United Kingdom. There he gained valuable experience in the blossoming field of DCD liver transplant and normothermic machine liver perfusion prior to returning to UCSF.

    Since returning to UCSF in 2015, Dr. Roll has specialized in abdominal organ transplantation for both adults and children, including liver and kidney transplant surgery from living donors, complex hepatobiliary surgery, and kidney autotransplants for intractable ureteral problems. He also performs general surgery in patients with end-stage organ disease and patients taking immunosuppression. His expertise includes using minimally invasive surgical techniques.

    Within UCSF, Dr. Roll is an investigator on several clinical trials looking at outcomes for organ transplant recipients and advance organ preservation. He has leadership roles in patient safety and quality improvement at UCSF, in addition to teaching medical students and residents in multiple forums. Outside of UCSF, he serves on the editorial board of multiple peer reviewed journals.

    Education

    Education

    Boston College, BS, Finance, 1995-1999
    Brandeis University, Post Baccalaureate, Premedical, 1999-2001
    Temple University School of Medicine, MD, 2001-2005

    Residencies

    University of California, San Francisco, General Surgery, 2005-2012

    Fellowships
    Abdominal Transplant
    Start Year
    2012
    End Year
    2014

    Board Certifications

    American Board of Surgery, General Surgery

    Clinical Expertise

    Ascites

    Bile Duct Cancer (Cholangiocarcinoma)

    Bile Duct Injuries

    Bile Duct Strictures

    Bridging Therapies to Downstage HCC in Liver Transplant Setting

    Choledochal Cysts

    Deceased Donor Organ Utilization

    Gallbladder Cancer

    Kidney Transplantation

    Laparoscopic Donor Nephrectomy

    Liver Biopsy

    Hepatocellular Carcinoma (Primary Liver Cancer)

    Liver Cysts

    Liver Metastases (Secondary Liver Cancer)

    Liver Resection

    Liver Transplantation

    Living Donor Kidney Transplantation

    Living Donor Liver Transplantation

    Normothetic Machine Liver Perfusion

    Organ Donation of Cardiovascular Death

    Pancreas Transplantation

    Pediatric Kidney Transplantation

    Pediatric Liver Transplantation

    Portal Hypertension

    Clinical Interests

    Transplantation
    HBP surgery

    Clinical Trials

    1. Related Conditions: Liver Transplant| Start Date: | End Date:
    2. Related Conditions: HIV/AIDS, Kidney Transplant| Start Date: | End Date:

    In the News

    October, 16, 2015 | UCSF Transplant Surgery

    Research Interests

    Cell therapy with hepatocytes and hepatocyte-like cells derived from stem cells.
    Role of miRNA in liver regeneration

    Normothetic machine liver perfusion

    Publications

    MOST RECENT PUBLICATIONS FROM A TOTAL OF 117
    1. Motivations and outcomes of compatible living donor-recipient pairs in paired exchange.
      Chipman V, Cooper M, Thomas AG, Ronin M, Lee B, Flechner S, Leeser D, Segev DL, Mandelbrot DA, Lunow-Luke T, Syed S, Hil G, Freise CE, Waterman AD, Roll GR| | PubMed
    2. Bariatric surgery prior to transplantation and risk of early hospital re-admission, graft failure, or death following kidney transplantation.
      Ku E, McCulloch CE, Roll GR, Posselt A, Grimes BA, Johansen KL| | PubMed
    3. Discrepant subtyping of blood type A2 living kidney donors: Missed opportunities in kidney transplantation.
      Garg N, Warnke L, Redfield RR, Miller KM, Cooper M, Roll GR, Chipman V, Thomas A, Leeser D, Waterman AD, Mandelbrot DA| | PubMed
    4. With the Proven Tenacity of Waitlist Mortality, Shouldn't We Resist the Urge to Make Mountains Out of Survival Statistic Molehills?
      Roll GR, Roberts JP| | PubMed
    5. Navigating in the Dark, Challenges Assessing the Liver-kidney Safety Net.
      Roll GR, Safa K, Yeh H| | PubMed
    6. Retransplantation After Living Donor Liver Transplantation: Data from the Adult to Adult Living Donor Liver Transplantation Study.
      Braun HJ, Grab JD, Dodge JL, Syed SM, Roll GR, Schwab MP, Liu IH, Glencer AC, Freise CE, Roberts JP, Ascher NL| | PubMed
    7. A case report: anaphylaxis to cefazolin during renal transplant surgery.
      Hemati K, Gierat S, Roll GR, Barreto Chang OL| | PubMed
    8. Standardizing Discharge Opioid Prescriptions in Kidney Transplant Patients Decreases Opioid Usage.
      Schwab ME, Braun HJ, Quan D, Roll GR, Budanova N, Ascher NL, Hirose R| | PubMed
    9. COVID-19 does not impact HLA antibody profile in a series of waitlisted renal transplant candidates.
      Roll GR, Lunow-Luke T, Braun HJ, Buenaventura O, Mallari M, Stock PG, Rajalingam R| | PubMed
    10. Association between Longer Travel Distance for Transplant Care and Access to Kidney Transplantation and Graft Survival in the United States.
      Whelan AM, Johansen KL, Brar S, McCulloch CE, Adey DB, Roll GR, Grimes B, Ku E| | PubMed